Drug Information

General Information
Drug ID
DR00539
Drug Name
Cefmetazole
Synonyms
(6R,7S)-7-(2-((Cyanomethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7S)-7-(2-((Cyanomethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, sodium salt; (6R,7S)-7-({[(cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-({[(cyanomethyl)thio]acetyl}amino)-7-(methyloxy)-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-[[2-(cyanomethylsulfanyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 6beta-{[(cyanomethyl)sulfanyl]acetamido}-6alpha-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}ceph-3-em-4-carboxylic acid; CMZ; CS 1170; CS-1170; Cefmetazole (USP/INN); Cefmetazole Monosodium Salt; Cefmetazole [USAN:INN]; Cefmetazolo; Cefmetazolo [INN-Spanish]; Cefmetazolum; Cefmetazolum [INN-Latin]; SKF 83088; U 72791; U-72791A
Drug Type
Small molecular drug
Indication Urinary tract and skin bacteria infections [ICD11: GC08] Approved [1]
Therapeutic Class
Antibiotics
Structure
3D MOL 2D MOL
Formula
C15H17N7O5S3
Canonical SMILES
CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)CSCC#N)OC)SC2)C(=O)O
InChI
InChI=1S/C15H17N7O5S3/c1-21-14(18-19-20-21)30-6-8-5-29-13-15(27-2,17-9(23)7-28-4-3-16)12(26)22(13)10(8)11(24)25/h13H,4-7H2,1-2H3,(H,17,23)(H,24,25)/t13-,15+/m1/s1
InChIKey
SNBUBQHDYVFSQF-HIFRSBDPSA-N
CAS Number
CAS 56796-20-4
Pharmaceutical Properties Molecular Weight 471.5 Topological Polar Surface Area 239
Heavy Atom Count 30 Rotatable Bond Count 9
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 12
XLogP
-0.6
PubChem CID
42008
PubChem SID
10303 , 104338473 , 11466728 , 11467848 , 11486516 , 123087792 , 124766309 , 126625684 , 126686221 , 131319170 , 134224281 , 134338424 , 135002546 , 135882605 , 136357157 , 137006381 , 140396436 , 152035638 , 15479323 , 160963622 , 162173144 , 164788224 , 175442148 , 179150673 , 184544918 , 198970111 , 223674319 , 226513671 , 251916490 , 251917837 , 252347145 , 252449370 , 34707577 , 46504461 , 47217057 , 47217058 , 47440545 , 47440546 , 48259496 , 48415716 , 50050974 , 50294685 , 57312636 , 58106756 , 632166 , 7847973 , 7978876 , 8177398 , 92251462 , 92712300
ChEBI ID
ChEBI:3489
TTD Drug ID
D05UBX
DT(s) Transporting This Drug OATP1B3 Transporter Info Organic anion transporting polypeptide 1B3 Substrate [2]
PEPT1 Transporter Info Peptide transporter 1 Substrate [3]
References
1 Cefmetazole was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Screening of antibiotics that interact with organic anion-transporting polypeptides 1B1 and 1B3 using fluorescent probes. Biol Pharm Bull. 2011;34(3):389-95.
3 Intestinal transport of beta-lactam antibiotics: analysis of the affinity at the H+/peptide symporter (PEPT1), the uptake into Caco-2 cell monolayers and the transepithelial flux. Pharm Res. 1999 Jan;16(1):55-61.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.